資源 » 參考數據庫 » 客戶發表文獻

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫藥類雜志引用近萬次，處于行業領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發表科研成果，再次證明GenScript 有能力幫助業內科學家Make research easy.

Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5 Stem Cells via Inhibition of Wnt and Notch Signaling.

Cell Mol Gastroenterol Hepatol. 2019;

ZhaJuan-Min，LiHua-Shan，LinQian，KuoWei-Ting，JiangZhi-Hui，TsaiPei-Yun，DingNing，WuJia，XuShao-Fang，WangYi-Tang，PanJian，ZhouXiu-Min，ChenKai，TaoMin，OdenwaldMatthew A，TamuraAtsushi，TsukitaSachiko，TurnerJerrold R，HeWe

Products/Services Used	Details	Operation
Catalog Antibody	… mL). Blue symbols indicate enteroids cultured without IL22. Sources of IL22, from left to right, were GenScript Z03350, GenScript Z02197, R&D 582ML-010, R&D 582ML-010/CF, and PeproTech 201-22 (gold symbols). Each …	Get A Quote

摘要

Epithelial regeneration is essential for homeostasis and repair of the mucosal barrier. In the context of infectious and immune-mediated intestinal disease， interleukin (IL) 22 is thought to augment these processes. We sought to define the mechanisms by which IL22 promotes mucosal healing.